Skip to content
ppharmaranks
Menu
Class IIOngoing

Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing… recall

FDA recall D-0348-2026 · initiated Dec 31, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 4, 2026How we research

Wizcure Pharmaa Private Limited recalled Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Re… in Dec 2025 — an FDA Class II recall (D-0348-2026) because Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Sterility could not be assured

The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

All lots

Quantity recalled: 11,520 cartons

Details

Product
Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.
Recalling company
Wizcure Pharmaa Private Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Distributed Nationwide in the USA
Initiated
Dec 31, 2025
FDA report date
Mar 4, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Re… recalled?
Wizcure Pharmaa Private Limited recalled Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Re… in Dec 2025 — an FDA Class II recall (D-0348-2026) because Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Re… recalled?
Per the FDA enforcement record, the reason for recall D-0348-2026 was: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Is a recalled Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Re… dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Re… are affected?
Distributed: Distributed Nationwide in the USA. The recall covers these lots — All lots. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0348-2026.

Source: openFDA Drug Enforcement record D-0348-2026

← All drug recalls